Loading...
Header Logo
Keywords
Last Name
Institution

Eyal Sagiv

TitleInstructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Critical Care
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sagiv E, Fasano RM, Luban NLC, Josephson CD, Stowell SR, Roback JD, Francis RO, Yee MEM. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease. Am J Hematol. 2018 05; 93(5):630-634. PMID: 29377292.
      View in: PubMed
    2. Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients. Transfusion. 2016 07; 56(7):1707-15. PMID: 26997031.
      View in: PubMed
    3. Sagiv E, Sheffer M, Kazanov D, Shapira S, Naumov I, Kraus S, Domany E, Arber N. Gene expression following exposure to celecoxib in humans: pathways of inflammation and carcinogenesis are activated in tumors but not normal tissues. Digestion. 2011; 84(3):169-84. PMID: 21546775.
      View in: PubMed
    4. Hall MJ, Liberman E, Dulkart O, Galazan L, Sagiv E, Shmueli E, Kazanov D, Hallak A, Moshkowitz M, Figer A, Kraus S, Inbar M, Neugut AI, Arber N. Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Ann Oncol. 2009 Sep; 20(9):1517-21. PMID: 19474113.
      View in: PubMed
    5. Sagiv E, Starr A, Rozovski U, Khosravi R, Altevogt P, Wang T, Arber N. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res. 2008 Apr 15; 68(8):2803-12. PMID: 18413748.
      View in: PubMed
    6. Liberman E, Naumov I, Kazanov D, Dvory-Sobol H, Sagiv E, Birkenfeld S, Deutsch V, Trakhtenbrot L, Moshkowitz M, Arber N. Malignant transformation of normal enterocytes following downregulation of Bak expression. Digestion. 2008; 77(1):48-56. PMID: 18349538.
      View in: PubMed
    7. Sagiv E, Arber N. The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Rev Gastroenterol Hepatol. 2008 Feb; 2(1):125-33. PMID: 19072375.
      View in: PubMed
    8. Sagiv E, Rozovski U, Kazanov D, Liberman E, Arber N. Gene expression analysis proposes alternative pathways for the mechanism by which celecoxib selectively inhibits the growth of transformed but not normal enterocytes. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6807-15. PMID: 18006783.
      View in: PubMed
    9. Giladi N, Dvory-Sobol H, Sagiv E, Kazanov D, Liberman E, Arber N. Gene therapy approach in prostate cancer cells using an active Wnt signal. Biomed Pharmacother. 2007 Oct; 61(9):527-30. PMID: 17904788.
      View in: PubMed
    10. Liberman E, Kraus S, Sagiv E, Dulkart O, Kazanov D, Arber N. The APC E1317Q and I1307K polymorphisms in non-colorectal cancers. Biomed Pharmacother. 2007 Oct; 61(9):566-9. PMID: 17920230.
      View in: PubMed
    11. Shpitz B, Giladi N, Sagiv E, Lev-Ari S, Liberman E, Kazanov D, Arber N. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion. 2006; 74(3-4):140-4. PMID: 17228149.
      View in: PubMed
    12. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Cancer. 2007 Jan 15; 109(2):188-97. PMID: 17149756.
      View in: PubMed
    13. Dvory-Sobol H, Sagiv E, Kazanov D, Ben-Ze'ev A, Arber N. Targeting the active beta-catenin pathway to treat cancer cells. Mol Cancer Ther. 2006 Nov; 5(11):2861-71. PMID: 17121933.
      View in: PubMed
    14. Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology. 2006 Aug; 131(2):630-9. PMID: 16890615.
      View in: PubMed
    15. Sagiv E, Kazanov D, Arber N. CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother. 2006 Jul; 60(6):280-4. PMID: 16824727.
      View in: PubMed
    Sagiv's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description